Non-specific ocular surface

The ocular surface is a complex anatomical and functional unit comprising the cornea, conjunctiva, and the pre-ocular tear film, which together maintain ocular health and clear vision (Source: StatPearls, Anatomy, Eye, 2023). It serves as the eye's first line of defense against environmental factors and provides the major refractive power for the visual system. Dysfunction of this unit leads to Ocular Surface Disease (OSD), a broad category including dry eye syndrome, which is characterized by a loss of tear film homeostasis and inflammation (Source: TFOS DEWS II Definition and Classification Report, 2017). While many drugs are applied to the ocular surface, the term "Non-specific ocular surface" refers to the anatomical region rather than a specific molecular target like a receptor or enzyme. Therapeutic interventions typically involve lubricants to supplement the tear film or anti-inflammatory agents to address underlying pathology (Source: Mayo Clinic, Dry Eye, 2023). Consequently, it is considered a site of drug action rather than a discrete therapeutic target in molecular pharmacology. Common treatments include artificial tears, which provide physical lubrication, and prescription drops that target specific immune pathways to reduce surface inflammation. Monitoring the health of this surface involves clinical tests such as tear break-up time and osmolarity measurements (Source: PubMed, PMID: 28736336). Overall, the ocular surface represents a critical interface between the eye and the environment, requiring precise regulation of its components for visual clarity.

Other names

Ocular surfaceCorneal-conjunctival surfaceEye surfaceOcular surface unit

Drugs acting on the ocular surface function through physical lubrication, replacement of tear components, or modulation of inflammatory cytokines and T-cell activation to restore the ocular microenvironment (Source: FDA, Restasis/Xiidra Prescribing Information).